Effect of glycyrrhizic acid on protein binding of diltiazem, verapamil, and nifedipine.
The effects of glycyrrhizic acid (GLZ) on protein binding of diltiazem, verapamil, and nifedipine were investigated. Protein binding studies (human serum, human serum albumin (HSA) and alpha1-acid glycoprotein (AAG)) were conducted using the equilibrium dialysis method with and without addition of GLZ. The binding parameters, such as the number of moles of bound drug per mole of protein, the number of binding sites per protein molecule, and the association constant, were estimated using the Scatchard plot. The serum binding of nifedipine, verapamil, and diltiazem was displaced with addition of GLZ, and the decreases of Ks for serum were observed. GLZ decreased the association constants of three drugs for HSA and AAG, while the binding capacity remained similar with addition of GLZ. Although the characteristics of interaction were not clear, GLZ seemed to mainly affect HSA binding of nifedipine rather than AAG binding, while GLZ seemed to affect both AAG- and HSA-bindings of verapamil and diltiazem resulting in a serum binding displacement.
Lee
Kyoung-Jin
KJ
LOCUS Pharmaceuticals, Inc., Blue Bell, PA, USA.
Park
Hye-Jeong
HJ
Shin
Young-Hee
YH
Lee
Chi-Ho
CH
D004110:Diltiazem / Q000378:metabolism*; D019695:Glycyrrhizic Acid / Q000494:pharmacology*; D006801:Humans; D008297:Male; D009543:Nifedipine / Q000378:metabolism*; D011485:Protein Binding / Q000187:drug effects / Q000502:physiology; D012709:Serum Albumin / Q000378:metabolism*; D014700:Verapamil / Q000378:metabolism*
D012709:Serum Albumin; D019695:Glycyrrhizic Acid; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine